ACN
Accenture plc
Featured
Avalo Therapeutics 2025 Financial Review
Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases. The company’s...
37 seconds ago
WeRide Inc. 2025 Financial Performance Review
Company Overview WeRide Inc. is a global leader in autonomous driving technology and the first publicly traded robotaxi company. Key...
Market News
View All
Futures Drift in Narrow Ranges as EquipmentShare.com, XOMA Royalty Set to Report Wednesday
Futures drift in narrow ranges ahead of a light earnings calendar, with EquipmentShare.com and XOMA Royalty reporting Thursday morning.
Williams-Sonoma Headlines Light Earnings Calendar with Q4 Reports from Five Smaller Companies
Light earnings calendar features Williams-Sonoma after the close, with five smaller companies reporting Q4 results across healthcare, financial services, and...
XOMA Reports Wednesday Morning as Healthcare Earnings Dominate Sparse Week
Futures flat ahead of sparse earnings calendar; XOMA reports Wednesday morning as healthcare names dominate the week's schedule.